These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 9164568)
1. Behavioral effects of N-cyanomethylmethamphetamine, a product derived from smoking methamphetamine with tobacco, in mice and rats. Sekine H; Nagao S; Kuribara H; Nakahara Y Pharmacol Biochem Behav; 1997; 57(1-2):167-72. PubMed ID: 9164568 [TBL] [Abstract][Full Text] [Related]
2. Abuse of smoking methamphetamine mixed with tobacco. V. Plasma metabolites of N-cyanomethylmethamphetamine, a pyrolysis product formed by smoking methamphetamine in tobacco, and the species difference between mouse and rat. Sekine H; Nagao S; Nakahara Y Biol Pharm Bull; 1996 Jun; 19(6):845-51. PubMed ID: 8799484 [TBL] [Abstract][Full Text] [Related]
3. Abuse of smoking methamphetamine mixed with tobacco. III. Urinary metabolites of N-cyanomethylmethamphetamine, a pyrolysis product formed by smoking methamphetamine in tobacco, and species difference in its metabolism between rat and mouse. Sekine H; Nagao S; Nakahara Y Xenobiotica; 1995 Jan; 25(1):49-58. PubMed ID: 7604606 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of behavioural stimulant effect of N-cyanomethylmethamphetamine, a main product of smoking methamphetamine mixed with tobacco: evaluation by ambulatory activity in mice. Kuribara H; Sekine H; Nakahara Y Pharmacol Toxicol; 1996 Jun; 78(6):374-80. PubMed ID: 8829196 [TBL] [Abstract][Full Text] [Related]
5. Effect of haloperidol on the behavioral stimulation by N-cyanomethylmethamphetamine, a main product of smoking methamphetamine mixed with tobacco. Kuribara H; Sekine H; Nakahara Y Eur J Pharmacol; 1996 Jun; 305(1-3):1-6. PubMed ID: 8813524 [TBL] [Abstract][Full Text] [Related]
6. Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine. Witkin JM; Savtchenko N; Mashkovsky M; Beekman M; Munzar P; Gasior M; Goldberg SR; Ungard JT; Kim J; Shippenberg T; Chefer V J Pharmacol Exp Ther; 1999 Mar; 288(3):1298-310. PubMed ID: 10027871 [TBL] [Abstract][Full Text] [Related]
7. Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues. Quinteros-Muñoz D; Sáez-Briones P; Díaz-Véliz G; Mora-Gutiérrez S; Rebolledo-Fuentes M; Cassels BK Behav Neurosci; 2010 Oct; 124(5):662-76. PubMed ID: 20939666 [TBL] [Abstract][Full Text] [Related]
8. A quantity of stereotyped behavior of ddY mice induced by low-dose methamphetamine. Masuda Y; Matsuda Y; Kondoh M; Shimizu T; Hishikawa Y Exp Anim; 1996 Jul; 45(3):279-81. PubMed ID: 8840148 [TBL] [Abstract][Full Text] [Related]
9. Selective breeding for magnitude of methamphetamine-induced sensitization alters methamphetamine consumption. Scibelli AC; McKinnon CS; Reed C; Burkhart-Kasch S; Li N; Baba H; Wheeler JM; Phillips TJ Psychopharmacology (Berl); 2011 Apr; 214(4):791-804. PubMed ID: 21088960 [TBL] [Abstract][Full Text] [Related]
10. Psychomotor effect differences between l-methamphetamine and d-methamphetamine are independent of murine plasma and brain pharmacokinetics profiles. Nishimura T; Takahata K; Kosugi Y; Tanabe T; Muraoka S J Neural Transm (Vienna); 2017 May; 124(5):519-523. PubMed ID: 28213761 [TBL] [Abstract][Full Text] [Related]
11. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats. Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M Neurochem Res; 2005 Nov; 30(11):1377-85. PubMed ID: 16341934 [TBL] [Abstract][Full Text] [Related]
12. Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Phillips TJ; Dickinson S; Burkhart-Kasch S Behav Neurosci; 1994 Aug; 108(4):789-803. PubMed ID: 7986372 [TBL] [Abstract][Full Text] [Related]
13. Methamphetamine-induced behavioural effects and brain concentrations of methamphetamine and its metabolite amphetamine in mice. Brien JF; Kitney JC; Peachey JE; Rogers BJ Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):313-28. PubMed ID: 569889 [TBL] [Abstract][Full Text] [Related]
14. Mazindol: anorectic and behavioral effects in female rats. Mattei R; Carlini EA Arch Int Pharmacodyn Ther; 1995; 330(3):279-87. PubMed ID: 8836447 [TBL] [Abstract][Full Text] [Related]
15. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats. Tsukamoto T; Iyo M; Tani K; Sekine Y; Hashimoto K; Ohashi Y; Suzuki K; Iwata Y; Mori N Psychopharmacology (Berl); 2001 Nov; 158(2):107-13. PubMed ID: 11702083 [TBL] [Abstract][Full Text] [Related]
16. A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Bryant CD; Graham ME; Distler MG; Munoz MB; Li D; Vezina P; Sokoloff G; Palmer AA Psychopharmacology (Berl); 2009 May; 203(4):703-11. PubMed ID: 19050854 [TBL] [Abstract][Full Text] [Related]
17. Effects of early adolescent methamphetamine exposure on anxiety-like behavior and corticosterone levels in mice. Rud MA; Do TN; Siegel JA Neurosci Lett; 2016 Oct; 633():257-261. PubMed ID: 27666973 [TBL] [Abstract][Full Text] [Related]
18. Ginsenosides attenuate methamphetamine-induced behavioral side effects in mice via activation of adenosine A2A receptors: possible involvements of the striatal reduction in AP-1 DNA binding activity and proenkephalin gene expression. Shin EJ; Nabeshima T; Suh HW; Jhoo WK; Oh KW; Lim YK; Kim DS; Choi KH; Kim HC Behav Brain Res; 2005 Mar; 158(1):143-57. PubMed ID: 15680202 [TBL] [Abstract][Full Text] [Related]
19. Effects of methamphetamine exposure on anxiety-like behavior in the open field test, corticosterone, and hippocampal tyrosine hydroxylase in adolescent and adult mice. Struntz KH; Siegel JA Behav Brain Res; 2018 Aug; 348():211-218. PubMed ID: 29680785 [TBL] [Abstract][Full Text] [Related]